Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

Company Participation - Lifecore Biomedical, Inc. will participate in the 2025 BIO CEO & Investor Conference scheduled for February 10-11, 2025, in New York, NY [1] - The company's management, including CEO Paul Josephs and CFO Ryan Lake, will engage in 1-on-1 meetings during the conference [1] Company Overview - Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products [2] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and serves global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories [2]